MUMBAI, India, April 28, 2026 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated results for the Fourth Quarter (Q4) and Full-year ended 31st March 2026....
Hence then, the article about piramal pharma limited announces results for q4 and full year fy26 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Piramal Pharma Limited Announces Results for Q4 and Full-year FY26 )
Also on site :
- Scienjoy Holding Corporation to Acquire 29.9% Stake in Chinese Higher Education Service Provider Leader Education Limited
- Sceye и SoftBank Corp. завершили в Японии демонстрационные испытания стратосферной связи, сделав очередной шаг к коммерциализации HAPS
- Sports CIOs Face Game-Day Risk as Venue Technology Ownership Remains Fragmented, Finds Info-Tech Research Group